NSE filing, NSE: MOS. Summary written from the filing by ALFA Finder's alert engine.
MOS Utility Ltd: key numbers
- Share price
- ₹7.25
- Market cap
- ₹186.6 Cr
- Revenue (annual)
- ₹635.2 Cr
- Net profit (annual)
- ₹18.00 Cr
- P/E (TTM)
- 10.4×Sector 22.9×
- Promoter holding
- 36.23%-19.46% QoQ
- FII holding
- 8.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from MOS Utility Ltd
All →MOS Utility Partnership
MOS Utility has partnered with Bharat Co-operative Bank (Mumbai) to facilitate digital payment services for merchants. The press release also notes RBI in-principle approvals for a subsidiary's payment businesses.
MOS Utility Annual General Meeting
MOS Utility Limited held its 17th Annual General Meeting on September 30, 2026, to discuss financial results and approve items including an employee stock option scheme.
MOS Utility Share Pledge
MOS Utility promoter Kurjibhai Rupareliya's pledge on 3 Crore shares was invoked on Aug 20, 2026. The pledgee is Ashok Investors Trust Limited via Nuvama Wealth.
MOS Utility Annual General Meeting
MOS Utility Limited has fixed September 23, 2026, as the cut-off date for determining member eligibility for e-voting at its 17th Annual General Meeting.
MOS Utility Board Meeting Outcome
MOS Utility Limited's board approved FY 2025-26 financial results, director re-appointment, secretarial auditor appointment, and a new ESOS 2026 scheme.
MOS Utility Board Meeting Date
Mos Utility Limited has scheduled a board meeting on September 3, 2026, to discuss and approve ESOPs and other business matters.
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.